Known as a fervent watchdog over the prices and cost-effectiveness of new pharmaceuticals, the Institute for Clinical and Economic Review (ICER) said in a report published early Thursday that all four Covid-19 outpatient treatments’ prices are adequately aligned with their benefits.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,